As Per the Report, the Europe Cell Counting Market Size was valued at USD 0.31 billion in 2022 and is expected to grow at a CAGR of 6.8%, to reach USD 0.43 billion by 2027 during the forecast period 2022 to 2027.
The increased incidence of target diseases such as HIV, measles, and diphtheria and chronic diseases such as cancer and other blood disorders is primarily driving market expansion. According to the World Health Organization (WHO), almost 7.9 million people in Europe were infected with HIV in 2018. The majority of this prevalence has been discovered in poor and middle-income nations.
Cell counters are becoming more widely used in various applications, including research, diagnostics, and industry. Cell counting instruments are increasingly being used in multiple fields of study, including cancer biology, immunology, and neuroscience, and the market is expected to grow exponentially. In addition, as the number of chronic diseases rises, the demand for tools increases.
Furthermore, the government's increasing financing for cell counting research boosts industry growth. The market expansion is supplemented by inspiring attitudes toward stem cell research, increased funding, and widespread awareness of stem cells.
The rising frequency of AIDS and cancer is one of the primary factors driving the worldwide cell counting industry. Cell counting is used to ensure intra-tumor heterogeneity, which is an essential step in tracking cancer growth in the patient's body.
Due to the high costs of the apparatus, equipment, and procedures, many people are hesitant to spend money on cell counting methods for medical or research purposes
Furthermore, most countries have underdeveloped healthcare infrastructure and antiquated technology, which severely hinders the growth of cell counting. Moreover, the cell counting market's progress is hampered by a scarcity of competent personnel.
The expansion of the market in Europe is being hampered by a scarcity of experienced professionals combined with insufficient research infrastructure, particularly in emerging markets.
This research report on the Europe Cell Counting Market has been segmented and sub-segmented into the following categories.
By End User:
Geographically, Europe is expected to have the second-highest share of the global cell counting market throughout the projected period. The significant portion is a larger patient pool and an aging population.
The United Kingdom Cell Counting Market and Germany Cell Counting Market have the largest market share in Europe, owing to an increasing number of chronic diseases and a growing number of research and development programs in the country.
Growing demand for high-tech instruments in research and diagnostic applications, high incidence of target conditions, increased focus on stem cell, biomedical, and cancer research, rising prevalence of chronic diseases, and growing demand for early diagnosis and effective treatment of diseases are all contributing to this segment's large share.
The rising number of stem cell, genomics, and proteomic research activities, the vast genome pool, the growing trend for research infrastructure modernization, low development costs, less complicated regulations, and increasing investments by pharmaceutical and biotechnology companies contribute to this growth.
The European cell counting market is expected to grow in the coming years due to the rising prevalence of chronic diseases and blood-related disorders, technological advancements in this segment, and the expanding biopharmaceutical and biotechnology industries.
KEY MARKET PLAYERS
Major Companies Operating the Europe Cell Counting Market are Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, Inc., GE Healthcare, Becton, Dickinson and Company, and PerkinElmer, Inc.,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
126.96.36.199 Cell Counters
188.8.131.52.1 Automated Cell Counters
184.108.40.206.2 Hemocytometers and Manual Cell Counters
220.127.116.11 Hematology Analysers
18.104.22.168.1 Single-Mode Readers
22.214.171.124.2 Multi-Mode Readers
126.96.36.199 Flow Cytometer
188.8.131.52 Assay Kits
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2.2 Pharmaceutical & Biotechnology Industries
5.2.3 Hospitals & Diagnostic Laboratories
5.2.4 Research & Academic Institutes
5.2.6 Y-o-Y Growth Analysis, By End-user
5.2.7 Market Attractiveness Analysis, By End-user
5.2.8 Market Share Analysis, By End-user
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By End-user
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Product
188.8.131.52 By End-user
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By End-user
6.7 Rest of Europe
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Thermo Fisher Scientific, Inc.,
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Danaher Corporation
8.3 Agilent Technologies
8.4 Bio-Rad Laboratories
8.5 Merck Millipore, Inc.,
8.6 GE Healthcare
8.7 Becton, Dickinson and Company
8.8 PerkinElmer, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.